Differential Pharmacokinetics of Liver Tropism for Iron Sucrose, Ferric Carboxymaltose, and Iron Isomaltoside: A Clue to Their Safety for Dialysis Patients
Sign Up to like & getrecommendations! Published in 2022 at "Pharmaceutics"
DOI: 10.3390/pharmaceutics14071408
Abstract: Anemia is a major complication of end-stage kidney disease (ESKD). Erythropoiesis-stimulating agents and intravenous (IV) iron are the current backbone of anemia treatment in ESKD. Iron overload induced by IV iron is a potential clinical… read more here.
Keywords: carboxymaltose iron; iron; ferric carboxymaltose; iron sucrose ... See more keywords
[Hypophosphatemia induced by carboxymaltose iron and imatinib. Report of two cases].
Sign Up to like & getrecommendations! Published in 2020 at "Revista medica de Chile"
DOI: 10.4067/s0034-98872020000300404
Abstract: Hypophosphatemia is a relatively frequent and a potentially serious adverse drug effect. Clinically it is characterized by bone pain and muscle weakness. There are several mechanisms by which a drug can induce hypophosphatemia and they… read more here.
Keywords: hypophosphatemia; hypophosphatemia induced; report two; carboxymaltose iron ... See more keywords